WEST PHARMACEUTICAL SERVICES INC Annual Deferred Income Tax Expense (Benefit) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
West Pharmaceutical Services Inc annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
  • West Pharmaceutical Services Inc Deferred Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was -$8M.
  • West Pharmaceutical Services Inc annual Deferred Income Tax Expense (Benefit) for 2023 was $37.5M.
  • West Pharmaceutical Services Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$30.8M, a 28.2% increase from 2021.
  • West Pharmaceutical Services Inc annual Deferred Income Tax Expense (Benefit) for 2021 was -$42.9M, a 640% decline from 2020.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $37.5M +$68.3M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 -$30.8M +$12.1M +28.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 -$42.9M -$37.1M -640% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 -$5.8M -$21.1M -138% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $15.3M +$14.4M +1600% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
2018 $900K -$40.8M -97.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 $41.7M +$20.2M +94% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 $21.5M +$30.4M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$8.9M -$15.9M -227% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 $7M +$5.3M +312% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $1.7M -$3.6M -67.9% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 $5.3M +$2.4M +82.8% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-25
2011 $2.9M +$4.7M Jan 1, 2011 Dec 31, 2011 10-K 2014-02-27
2010 -$1.8M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.